User:Mr. Ibrahem/Olodaterol

Olodaterol, sold under the brand name Striverdi, is a long-acting β adrenoreceptor agonist (LABA) used to treat chronic obstructive pulmonary disease (COPD). Use is not recommended in asthma. It is breathed into the lungs.

Common side effects include cough, diarrhea, joint pain, rash, and runny nose. Other side effects may include QT prolongation and bronchospasm. In asthma there are concerns regarding an increased risk of death. While there is no evidence of harm in pregnancy, such use has not been well studied.

Olodaterol was approved for medical use in the United States in 2014. It is also available in combination with tiotropium as a single inhaler. In the United Kingdom a month of medication costs the NHS about £26 as of 2021. In the United States this amount costs about US$230.